Alignment Healthcare Inc has a consensus price target of $12.73, established from looking at the 47 latest analyst ratings. The last 3 analyst ratings were released from Stifel, Piper Sandler, and Barclays on April 23, 2024, March 6, 2024, and March 6, 2024. With an average price target of $6.5 between Stifel, Piper Sandler, and Barclays, there's an implied 25.48% upside for Alignment Healthcare Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/23/2024 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 73.75% | Stifel | Craig Jones | $11 → $9 | Maintains | Buy | Get Alert |
03/06/2024 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 15.83% | Piper Sandler | Jessica Tassan | $12 → $6 | Downgrade | Overweight → Neutral | Get Alert |
03/06/2024 | ALHC | Buy Now | Alignment Healthcare | $5.18 | -13.13% | Barclays | Andrew Mok | → $4.5 | Initiates | → Underweight | Get Alert |
02/28/2024 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 64.09% | UBS | Kevin Caliendo | $9 → $8.5 | Maintains | Neutral | Get Alert |
01/24/2024 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 112.36% | Stifel | Craig Jones | → $11 | Initiates | → Buy | Get Alert |
01/09/2024 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 131.66% | Raymond James | John Ransom | $10 → $12 | Maintains | Strong Buy | Get Alert |
01/09/2024 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 102.7% | Stephens & Co. | Scott Fidel | $10 → $10.5 | Maintains | Equal-Weight | Get Alert |
12/21/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 73.75% | UBS | Kevin Caliendo | $6.5 → $9 | Maintains | Neutral | Get Alert |
11/02/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 39.96% | B of A Securities | Kevin Fischbeck | → $7.25 | Downgrade | Buy → Neutral | Get Alert |
10/16/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 93.05% | Raymond James | John Ransom | $9 → $10 | Upgrade | Outperform → Strong Buy | Get Alert |
10/12/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 73.75% | Stephens & Co. | Scott Fidel | → $9 | Initiates | → Equal-Weight | Get Alert |
08/30/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 131.66% | Morgan Stanley | Ricky Goldwasser | $19 → $12 | Maintains | Overweight | Get Alert |
07/14/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 266.8% | Morgan Stanley | Ricky Goldwasser | $19 → $19 | Reiterates | Overweight → Overweight | Get Alert |
07/13/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 15.83% | UBS | Kevin Caliendo | $8 → $6 | Maintains | Neutral | Get Alert |
07/07/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 93.05% | JP Morgan | Lisa Gill | $12 → $10 | Maintains | Neutral | Get Alert |
05/01/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 73.75% | Raymond James | John Ransom | → $9 | Upgrade | Market Perform → Outperform | Get Alert |
04/19/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 131.66% | Goldman Sachs | Nathan Rich | $14 → $12 | Maintains | Buy | Get Alert |
03/03/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 170.27% | Goldman Sachs | Nathan Rich | $21 → $14 | Maintains | Buy | Get Alert |
03/03/2023 | ALHC | Buy Now | Alignment Healthcare | $5.18 | 131.66% | Piper Sandler | Jessica Tassan | $19 → $12 | Maintains | Overweight | Get Alert |
The latest price target for Alignment Healthcare (NASDAQ: ALHC) was reported by Stifel on April 23, 2024. The analyst firm set a price target for $9.00 expecting ALHC to rise to within 12 months (a possible 73.75% upside). 16 analyst firms have reported ratings in the last year.
The latest analyst rating for Alignment Healthcare (NASDAQ: ALHC) was provided by Stifel, and Alignment Healthcare maintained their buy rating.
The last upgrade for Alignment Healthcare Inc happened on October 16, 2023 when Raymond James raised their price target to $10. Raymond James previously had an outperform for Alignment Healthcare Inc.
The last downgrade for Alignment Healthcare Inc happened on March 6, 2024 when Piper Sandler changed their price target from $12 to $6 for Alignment Healthcare Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alignment Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alignment Healthcare was filed on April 23, 2024 so you should expect the next rating to be made available sometime around April 23, 2025.
While ratings are subjective and will change, the latest Alignment Healthcare (ALHC) rating was a maintained with a price target of $11.00 to $9.00. The current price Alignment Healthcare (ALHC) is trading at is $5.18, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.